Tel Aviv, Israel

Alon Peled

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Ichilov Tech Ltd., Tel Aviv University. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alon Peled: Innovator in Dermatological Treatments

Introduction

Alon Peled is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of dermatology through his innovative approaches to treating skin diseases. His work focuses on addressing conditions that involve accelerated corneodesmosomes degradation and weakened cell-cell adhesion.

Latest Patents

Alon Peled holds a patent for a method and composition aimed at treating skin diseases associated with accelerated corneodesmosomes degradation or weaker cell-cell adhesion. This patent addresses conditions such as peeling skin syndrome, Netherton syndrome, and atopic dermatitis. The invention provides a pharmaceutical composition that offers new hope for patients suffering from these challenging skin disorders.

Career Highlights

Throughout his career, Alon Peled has been associated with prominent institutions, including Ichilov Tech Ltd. and Tel Aviv University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in dermatology.

Collaborations

Alon Peled has worked alongside esteemed colleagues such as Eli Sprecher and Ofer Sarig. Their combined expertise has further advanced the understanding and treatment of skin diseases.

Conclusion

Alon Peled's innovative contributions to dermatological treatments highlight his commitment to improving patient care. His patent and collaborations reflect a dedication to addressing complex skin conditions, making a significant impact in the field of dermatology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…